Clinical Trial Update: The Clinical Validity and Safety of IOP Injection MRI Contrast Agent in Hepatocellular Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the validity and safety of an MRI contrast agent injected intraocularly? (IOP) for hepatocellular carcinoma imaging has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: MegaPro Biomedical Co. Ltd. | Conditions: Magnetic Resonance Imaging | Phase 2 | Status: COMPLETED